Primary Record
GSK2578215A
- In stock
- 4,217 g
- Purity
- 98.5 %
- CAS
- 1285515-21-0
Compound Identifiers & Properties
- CAS
- 1285515-21-0
- PubChem CID
- 68107965
- SMILES
- C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4
- Canonical SMILES
- O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1
Names & Synonyms
- GSK2578215A
- 1285515-21-0
- SMANT hydrochloride
- GSK-2578215A
- 2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide
- LRRK2-kinase inhibitor
- UNII-Q641JSF42X
- MFCD22665702
- itor GSK2578215A
- Q641JSF42X
- CHEMBL2204495
- C24H18FN3O2
- WCIGMFCFPXZRMQ-UHFFFAOYSA-N
- GSK257821A
- orb1305949
- SCHEMBL10321469
- SCHEMBL29430005
- SCHEMBL29430025
- AOB6080
- BDBM482159
- GLXC-05797
- HMS3740I09
- HMS6018O05
- BCP07701
- EX-A1118
- GSK 257821A
- GSK-257821A
- KS-00000T3G
- 2446AH
- BDBM50401284
- GSK 2578215A
- GSK2578215-A
- LRRK2 inhibitor GSK2578215A?
- s7664
- ZINC68267183
- Benzamide, 5-(2-fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinyl-
- AKOS024458262
- LRRK2 inhib1285515-21-0
- CCG-268642
- CS-3516
- GSK2578215
- NCGC00370783-04
- NCGC00370783-06
- NCGC00370783-10
- AC-35433
- AK174163
- AS-72347
- BC600629
- CID:68107965
- DA-33593
- HY-13237
- QC-11747
- SY116005
- 5-(2-fluoropyridin-4-yl)-2-phenylmethoxy-N-pyridin-3-ylbenzamide
- SID:508839324
- B5659
- FT-0700156
- J3.759.617E
- A12798
- F50677
- A889008
- 5-(2-Fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinylbenzamide
- 2-benzyloxy-5-(2-fluoro-4-pyridyl)-N-(3-pyridyl)benzamide
- Q27287044
- C000600930
- 2-(Benzyloxy)-5-(2-fluoro-4-pyridyl)-N-(3-pyridyl)benzamide
- 5-(2-Fluoro-4-pyridinyl)-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide